TR200201245T2 - Oncolytic combinations for cancer treatment. - Google Patents

Oncolytic combinations for cancer treatment.

Info

Publication number
TR200201245T2
TR200201245T2 TR2002/01245T TR200201245T TR200201245T2 TR 200201245 T2 TR200201245 T2 TR 200201245T2 TR 2002/01245 T TR2002/01245 T TR 2002/01245T TR 200201245 T TR200201245 T TR 200201245T TR 200201245 T2 TR200201245 T2 TR 200201245T2
Authority
TR
Turkey
Prior art keywords
cancer treatment
oncolytic
combinations
oncolytic combinations
ltb4
Prior art date
Application number
TR2002/01245T
Other languages
Turkish (tr)
Inventor
Herbert Fleisch Jerome
Stuart Benjamin Roger
Scott Sawyer Jason
Ann Teicher Beverly
Wade Beight Douglas
C. R. Smith Edward
Thomas Mcmillen William
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of TR200201245T2 publication Critical patent/TR200201245T2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)

Abstract

Lökotrien (LTB4) antagonistleri, 2', 2'-difloronükleosid kanser karsiti maddelerin etkililigini artirirlar.Leukotriene (LTB4) antagonists enhance the efficacy of 2 ', 2'-difluoronucleoside anti-cancer agents.

TR2002/01245T 1999-11-11 2000-11-09 Oncolytic combinations for cancer treatment. TR200201245T2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16478699P 1999-11-11 1999-11-11

Publications (1)

Publication Number Publication Date
TR200201245T2 true TR200201245T2 (en) 2004-08-23

Family

ID=22596085

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2002/01245T TR200201245T2 (en) 1999-11-11 2000-11-09 Oncolytic combinations for cancer treatment.

Country Status (22)

Country Link
EP (1) EP1231938A2 (en)
JP (1) JP2003513916A (en)
KR (1) KR20020069512A (en)
CN (1) CN1390139A (en)
AR (1) AR032432A1 (en)
AU (1) AU778829B2 (en)
BR (1) BR0015490A (en)
CA (1) CA2391416A1 (en)
CZ (1) CZ20021551A3 (en)
EA (1) EA200200545A1 (en)
HK (1) HK1050132A1 (en)
HU (1) HUP0204449A3 (en)
IL (1) IL148579A0 (en)
MX (1) MXPA02004733A (en)
NO (1) NO20022245L (en)
NZ (1) NZ517667A (en)
PE (1) PE20010701A1 (en)
PL (1) PL355172A1 (en)
SK (1) SK6492002A3 (en)
TR (1) TR200201245T2 (en)
WO (1) WO2001034137A2 (en)
ZA (1) ZA200202822B (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6797723B1 (en) 1999-11-11 2004-09-28 Eli Lilly And Company Heterocycle substituted diphenyl leukotriene antagonists
WO2001034198A2 (en) * 1999-11-11 2001-05-17 Eli Lilly And Company Oncolytic combinations for the treatment of cancer
AU1916501A (en) * 1999-11-11 2001-06-06 Eli Lilly And Company Oncolytic combinations for the treatment of cancer
JP2001247459A (en) 2000-03-03 2001-09-11 Oakland Uniservices Ltd Combination therapy for cancer
EP1326605A4 (en) * 2000-05-09 2004-03-17 Univ Creighton Methods for inhibiting proliferation and inducing apoptosis in cancer cells
AU2001282717A1 (en) 2000-07-28 2002-02-13 Cancer Research Technology Limited Cancer treatment by combination therapy
GB0121285D0 (en) 2001-09-03 2001-10-24 Cancer Res Ventures Ltd Anti-cancer combinations
GB2386836B (en) 2002-03-22 2006-07-26 Cancer Res Ventures Ltd Anti-cancer combinations
GB2394658A (en) 2002-11-01 2004-05-05 Cancer Rec Tech Ltd Oral anti-cancer composition
US7968723B2 (en) 2004-05-05 2011-06-28 High Point Pharmaceuticals, Llc Compounds, their preparation and use
US8053598B2 (en) 2004-05-05 2011-11-08 High Point Pharmaceuticals, Llc Compounds, their preparation and use
CN1302782C (en) * 2005-01-17 2007-03-07 北京京卫燕康药物研究所有限公司 Jixitabing hydrochloride solution type injection agent
EP2298742B1 (en) 2005-06-30 2014-01-08 High Point Pharmaceuticals, LLC phenoxy acetic acids as PPAR delta activators
BRPI0620468A2 (en) 2005-12-22 2011-11-08 Transtech Pharma Inc acetic phenoxy acids as activators of delta ppar
CA2645719A1 (en) 2006-03-09 2007-09-13 High Point Pharmaceuticals, Llc Compounds that modulate ppar activity, their preparation and use
AU2007307597A1 (en) 2006-10-12 2008-04-17 Institute Of Medicinal Molecular Design. Inc. Carboxylic acid derivatives
US8633245B2 (en) 2008-04-11 2014-01-21 Institute Of Medicinal Molecular Design, Inc. PAI-1 inhibitor
WO2014060381A1 (en) 2012-10-18 2014-04-24 Bayer Cropscience Ag Heterocyclic compounds as pesticides
BR112015009751A2 (en) 2012-10-31 2017-07-11 Bayer Cropscience Ag new heterocyclic compounds as pesticides
CN103319466B (en) * 2013-07-04 2016-03-16 郑州大学 Containing the 1,2,3-triazoles-dithiocarbamates compound of tonka bean camphor parent nucleus, preparation method and application thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6034256A (en) * 1997-04-21 2000-03-07 G.D. Searle & Co. Substituted benzopyran derivatives for the treatment of inflammation

Also Published As

Publication number Publication date
BR0015490A (en) 2002-07-09
SK6492002A3 (en) 2003-09-11
EA200200545A1 (en) 2002-12-26
PL355172A1 (en) 2004-04-05
IL148579A0 (en) 2002-09-12
AU1599001A (en) 2001-06-06
JP2003513916A (en) 2003-04-15
AU778829B2 (en) 2004-12-23
NO20022245L (en) 2002-07-09
HUP0204449A2 (en) 2003-04-28
EP1231938A2 (en) 2002-08-21
CA2391416A1 (en) 2001-05-17
MXPA02004733A (en) 2002-08-30
NO20022245D0 (en) 2002-05-10
AR032432A1 (en) 2003-11-12
ZA200202822B (en) 2003-09-23
CZ20021551A3 (en) 2003-02-12
CN1390139A (en) 2003-01-08
WO2001034137A2 (en) 2001-05-17
NZ517667A (en) 2004-05-28
HUP0204449A3 (en) 2006-02-28
HK1050132A1 (en) 2003-06-13
PE20010701A1 (en) 2001-07-07
KR20020069512A (en) 2002-09-04
WO2001034137A3 (en) 2002-02-14

Similar Documents

Publication Publication Date Title
TR200201245T2 (en) Oncolytic combinations for cancer treatment.
BR0216099B1 (en) "WEAR SET".
PT960107E (en) 6-TIO-SUBSTITUTED PACLITAXEL COMPOUNDS
ATE293618T1 (en) 4, 5, 6, 7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTI-TUMOR AGENTS
BR0207378A (en) Cancer treatment
DE69925133D1 (en) PYRROLOBENZODIAZEPINE
TR200202194T2 (en) Polyglutamic acid-camptothecin compounds and preparation methods
DE60040981D1 (en) TREATMENT WITH ANTI-ErbB2 ANTIBODIES
ATE231872T1 (en) THIAZOLOPYRIMIDE DERIVATIVES
ZA993345B (en) Nefazodone dosage form.
DE60216233D1 (en) Carbolinderivate
DE60115466D1 (en) ACTIVE PROCESSORS OF IMIDAZOPYRIDINE DERIVATIVES
WO2001034198A3 (en) Oncolytic combinations for the treatment of cancer
DE60112960D1 (en) CONDENSED PYRIDOINDOL DERIVATIVES
DK1204659T3 (en) Serotonergic benzofurans
ITRM990426A0 (en) USE OF SUBSTANCE P INHIBITORS FOR THE TREATMENT OF ADENOCARCINOMAS.
TR200302134T4 (en) Use of 2-methyl-thiazolidine-2,4-dicarboxylic acid and / or physiologically acceptable salts thereof as anti-cancer agents.
WO2001034134A3 (en) Oncolytic combinations for the treatment of cancer
TR199901017A2 (en) Insecticide composition.
DE60121048D1 (en) PYRAZINOi1'2 ': 1,6öPYRIDOi3,4-BöINDOLDERIVATE
ZA200205470B (en) Virus strains for the oncolytic treatment of cancer.
HK1050533A1 (en) Substituted pyrroles as antiproliferative agents for the treatment of cancer.
ATE250340T1 (en) 7-METHYLTHIOOXOMETHYL AND 7-METHYLTHIODIOXOMETHYL PACLITAXELE
NO20020914L (en) Alkoxy-substituted benzimidazole compounds, preparations containing them and their applications
ITTO20010222A1 (en) OLIVE TREATMENT MACHINE.